Skip to content

Psychedelic-assisted therapy: all studies

Page 276 of 294: studies 2,751 to 2,760 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

THE RECEPTION OF C.G. JUNG IN US DEATH AND DYING STUDIES

Phanês Journal For Jung History November 19, 2018 Jelena Martinovic 1 citation

C.G. Jung’s work has had a noticeable impact on conceptions about death and the dying experience, as well as on the therapeutic work methods that deal with anxiety, depression or terminal illnesses. This article analyses the reception of C.G. Jung’s work in the United States during the time period 1960-80. It examines ways in which Jung’s concepts were discussed and applied by psy practitioners...

DOI: 10.32724/phanes.2018.martinovic (opens in new tab) Mysticism Thanatology Psychoanalysis Transpersonal psychology +10

Why MDMA therapy for alcohol use disorder? And why now?

Neuropharmacology November 1, 2018 Ben Sessa 61 citations

Alcohol use disorder represents a serious clinical, social and personal burden on its sufferers and a significant financial strain on society. Current treatments, both psychological and pharmacological are poor, with high rates of relapse after medical detoxification and dedicated treatment programs. The earliest historical roots of psychedelic drug-assisted psychotherapy in the 1950s were...

Rapid-Acting Antidepressants

Current Pharmaceutical Design October 19, 2018 Jeffrey M. Witkin, Daniel E. Knutson, Gabriel J. Rodriguez et al. 44 citations

Background: Conventional antidepressants are thought to produce their impact on clinical symptoms by increasing the central availability of biogenic amine neurotransmitters (the monoamine hypothesis of depression). These drugs continue to be the primary medicines used in major depressive disorder. Although they have biological effects after acute dosing, full antidepressant response generally...

DOI: 10.2174/1381612824666180730104707 (opens in new tab) Pharmacology Intensive care medicine

The Repression and Support of Psychedelic Experience

September 24, 2018 Ted M. Clark, Dennis T. Jaffe

A Gallup Poll reports that the nation&s;s college students have tried psychedelic drugs — an increase of 1800 percent in the past four years — at a time when the government has halted most research on the uses of these drugs as too dangerous and spends millions of dollars to control their use. Psychedelic drugs are powerful and unpredictable, and sometimes result in difficulties which need...

Tua o te Aria. Doorways into Dying

Ata: Journal of Psychotherapy Aotearoa New Zealand September 24, 2018 Kay Ryan

As we age or become terminally ill, we are confronted by our mortality. Being confronted by our own or another’s death can be a time of accelerated and profound growth and development. Using examples from research and personal experience working in a hospice, this article explores challenges facing our own dying as well as that of clients and family members. It discusses the relevance and...

DARK Classics in Chemical Neuroscience: Ibogaine

ACS Chemical Neuroscience September 14, 2018 Michael Wasko, Paula A. Witt‐enderby, Christopher K. Surratt 63 citations

The West African iboga plant has been used for centuries by the Bwiti and Mbiri tribes to induce hallucinations during religious ceremonies. Ibogaine, the principal alkaloid responsible for iboga's psychedelic properties, was isolated and sold as an antidepressant in France for decades before its adverse effects precipitated its removal from the market. An ibogaine resurgence in the 1960s was...

DOI: 10.1021/acschemneuro.8b00294 (opens in new tab) Hallucinogen Nicotine Synthetic cannabinoids Nicotinic acetylcholine receptor +2

Psychedelics and music: neuroscience and therapeutic implications

International Review of Psychiatry July 4, 2018 Frederick S. Barrett, Katrin H. Preller, Mendel Kaelen 85 citations

From the beginning of therapeutic research with psychedelics, music listening has been consistently used as a method to guide or support therapeutic experiences during the acute effects of psychedelic drugs. Recent findings point to the potential of music to support meaning-making, emotionality, and mental imagery after the administration of psychedelics, and suggest that music plays an...

Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress

International Review of Psychiatry July 4, 2018 Stephen Ross 103 citations

Cancer is highly prevalent and one of the leading causes of global morbidity and mortality. Psychological and existential suffering is common in cancer patients, associated with poor psychiatric and medical outcomes. Promising early-phase clinical research (1960s to early 1970s) suggested a therapeutic signal for serotoninergic psychedelics (e.g. psilocybin, LSD) in treating cancer-related...

Psychedelics and hypnosis: Commonalities and therapeutic implications.

Journal of Psychopharmacology July 1, 2018 Clément E Lemercier, Devin B. Terhune

Recent research on psychedelics and hypnosis demonstrates the value of both methods in the treatment of a range of psychopathologies with overlapping applications and neurophenomenological features. The potential of harnessing the power of suggestion to influence the phenomenological response to psychedelics toward more therapeutic action has remained unexplored in recent research and thereby...

DOI: 10.1177/0269881118780714 (opens in new tab) Full text (opens in new tab) Consciousness Hypnosis Psychedelics Psychotherapy +1

Considerations on the current state of psychedelics therapy: limitations, bias and methodological proposals

Repositorio Universidad de Caldas July 1, 2018 Genís Ona

Objetivo. Evaluar el estado de la investigación actual sobre el potencial terapéutico de las sustancias psicodélicas. Metodología. Se realiza una breve revisión temática y se desarrolla un análisis crítico de la situación. Resultados. Se identifican diversas limitaciones y sesgos tanto en estudios observacionales como en ensayos clínicos. Conclusiones. Actualmente se cometen errores remarcables...